2023 annual financial data
Adaptive Biotechnologies 2023 Operating margin
Adaptive Biotechnologies 2023 operating margin with verified reported values.
Direct answer
Operating margin was -133.33%.
Operating income was -227,035,000 USD and net income was -225,250,000 USD.
Operating cash flow was -156,324,000 USD.
Get free Adaptive Biotechnologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 170,276,000 USD
- Operating income
- -227,035,000 USD
- Net income
- -225,250,000 USD
- Operating cash flow
- -156,324,000 USD